Matthew P. Patricelli

Author

Also Known As

M. P. PATRICELLI, M. P. Patricelli, M. Patricelli, Matthew P Patricelli, Matthew P. Patricelli, Matthew Patricelli, Matthew P. Patricelli

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

Scripps Research Institute Dana-Farber Cancer Institute Harvard University Torrey Pines Institute For Molecular Studies Wellspring Biosciences (United States)

About

Matthew P. Patricelli is an author at Scripps Research Institute specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	4.5K
2	Biochemistry	13	14	2.4K
3	Natural Sciences	12	13	2.7K
4	Health Sciences	1	1	16
5	Social Sciences	1	1	130

Matthew P. Patricelli

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli, Proceedings of the National Academy of Sciences	2001	1.3K
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor Matthew R. Janes, Jingchuan Zhang, Lian‐Sheng Li, Cell Kras Mutant CancersMedicineAnti-cancer AgentCancer BiologyRadiation Oncology	2018	1.1K
Activity-based protein profiling: The serine hydrolases Yongsheng Liu, Matthew P. Patricelli, Benjamin F. Cravatt Proceedings of the National Academy of Sciences Protein ChemistryProtein FunctionBiochemistryProtein FoldingNatural Sciences	1999	1.1K
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State Matthew P. Patricelli, Matthew R. Janes, Lian‐Sheng Li, Cancer Discovery	2016	731
Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates Matthew P. Patricelli, Anna Katrin Szardenings, Marek Liyanage, Biochemistry Signal Transduction PathwaysBiochemistryProtein FoldingNatural SciencesBioanalysis	2006	427
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2 Xianming Deng, Nicolas Dzamko, Alan R. Prescott, Nature Chemical Biology Signal TransductionMedicineReceptor Tyrosine KinaseDisease Kinase Lrrk2Selective Inhibitor	2011	425
In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases Matthew P. Patricelli, Tyzoon Nomanbhoy, Jiangyue Wu, Chemistry & Biology Signal TransductionSignaling PathwayCell RegulationMedicineNatural Sciences	2011	353
Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways Tsui‐Fen Chou, Steve Brown, Dmitriy Minond, Proceedings of the National Academy of Sciences	2011	320
Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes Matthew P. Patricelli, Dan K. Giang, Lisa M. Stamp, PROTEOMICS	2001	279
Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide Dale L. Boger, Haruhiko Sato, Aaron E. Lerner, Proceedings of the National Academy of Sciences	2000	272

Page 1